why choose us

First received: August 15, 2023

Clinical Trial: First in Human Study of TORL-4-500 in Participants With Advanced Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Solid Tumor

Study Type: INTERVENTIONAL


Official Title: A Phase 1, First in Human, Dose-Escalation Study of TORL-4-500 in Participants With Advanced Cancer

Brief Summary: This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-4-500 in patients with advanced cancer

Read more